Renal artery stenosis as a cause of renal impairment: implications for treatment of hypertension and congestive heart failure

Sever P , Beevers G , Bulpitt C Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society. BMJ 1993; 306: 983–7.

Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Sixth report. (JNC VI). Arch Intern Med 1997; 157: 2413–46.

Kannel WB. Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA 1996; 275: 1571–6.

Black HR , Elliott WJ , Neaton JD Rationale and design for the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) Trial. Control Clin Trials 1998; 19: 370–90.

Troisi E , Attanasio A , Matteis M Cerebral hemodynamics in young hypertensive subjects and effects of atenolol treatment. J Neurol Sci 1998; 159: 115–19.

Cohen A , Bregman B , Agabiti Rosei E Comparison of irbesartan vs felodipine in the regression after 1 year of left ventricular hypertrophy in hypertensive patients (the SILVER trial). Study of Irbesartan in Left Ventricular hypertrophy Regression. J Hum Hypertens 1998; 12: 479–83.

Wilson TW , Lacourciere Y , Barnes CC. The antihypertensive efficacy of losartan and amlodipine assessed with office and ambulatory blood pressure monitoring. Canadian Cozaar Hyzaar Amlodipine Trial Study Group. Can Med Assoc J 1998; 159: 469–76.

Lorimer AR , Lyons D , Fowler G , Petrie JC , Rothman MT. Differences between amlodipine and lisinopril in control of clinic and twenty-four hour ambulatory blood pressures. J Hum Hypertens 1998; 12: 411–16.

Weir MR , Reisin E , Falkner B , Hutchinson HG , Sha L , Tuck ML. Nocturnal reduction of blood pressure and the antihypertensive response to a diuretic or angiotensin converting enzyme inhibitor in obese hypertensive patients. TROPHY Study Group. Am J Hypertens 1998; 11: 914–20.

Scholze J , Stapff M. Start of therapy with the angiotensin II antagonist losartan after immediate switch from pretreatment with an ACE inhibitor. Br J Clin Pharmacol 1998; 46: 169–72.

Zannad F , Chati Z , Guest M , Plat F. Differential effects of fosinopril and enalapril in patients with mild to moderate chronic heart failure. Fosinopril in Heart Failure Study Investigators. Am Heart J 1998; 136: 672–80.

Hoglund C , Hutchinson HG. A comparison of nisoldipine coat-core and felodipine in the treatment of mild-to-moderate hypertension. Int J Clin Pract 1998; 52: 221–5.

Tedesco MA , Ratti G , Aquino D Effects of losartan on hypertension and left ventricular mass: a long-term study. J Hum Hypertens 1998; 12: 505–10.

Pepine CJ , Handberg-Thurmond E , Marks RG Rationale and design of the International Verapamil SR/Trandolapril Study (INVEST): an Internet-based randomized trial in coronary artery disease patients with hypertension. J Am Coll Cardiol 1998; 32: 1228–37.

Cifkova R , Peleska J , Hradec J Valsartan and atenolol in patients with severe essential hypertension. J Hum Hypertens 1998; 12: 563–7.

Hall WD , Reed JW , Flack JM , Yunis C , Preisser J. Comparison of the efficacy of dihydropyridine calcium channel blockers in African American patients with hypertension. ISHIB Investigators Group. International Society on Hypertension in Blacks. Arch Intern Med 1998; 158: 2029–34.

Reif M , White WB , Fagan TC Effects of candesartan cilexetil in patients with systemic hypertension. Candesartan Cilexetil Study Investigators. Am J Cardiol 1998; 82: 961–5.

Girvin B , Johnston GD. A randomized comparison of a conventional dose, a low dose and alternate-day dosing of bendrofluazide in hypertensive patients. J Hypertens 1998; 16: 1049–54.

Preston RA , Materson BJ , Reda DJ. Age-race subgroup compared with renin profile as predictors of blood pressure response to antihypertensive therapy. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. JAMA 1998; 280: 1168–72.

Wallis EJ , Ramsay LE , Hettiarachchi J. Combined inhibition of neutral endopeptidase and angiotensin-converting enzyme by sampatrilat in essential hypertension. Clin Pharmacol Ther 1998; 64: 439–49.

Risler T , Bohm R , Wetzchewald D , Nast HP , Koch HH , Stein G , Erley CM. A comparison of the antihypertensive efficacy and safety of felodipine IV and nifedipine IV in patients with hypertensive crisis or emergency not responding to oral nifedipine. Eur J Clin Pharmacol 1998; 54: 295–8.

Bagatin J , Sardelic S , Pivac N. Comparison of chlorthalidone, propranolol and bopindolol in six-month treatment of arterial hypertension. Int J Clin Pharmacol Res 1998; 18: 73–8.

Breithaupt-Grögler K , Gerhardt G , Lehmann G , Notter T , Belz G. Blood pressure and aortic elastic properties—verapamil SR/trandolapril compared to a metoprolol/hydrochlorothiazide combination therapy. Int J Clin Pharmacol Ther 1998; 36: 425–31.

Goldblatt H , Haas E , Klick RL , Lewis LV. The effect of main artery occlusion of one kidney on blood pressure of dogs. Proc Nat Acad Sci USA 1976; 73: 1722–4.

Stanley JC. Surgical treatment of renovascular hypertension. Am J Surg 1997; 174: 102–10.

Scoble JE , Maher ER , Hamilton G , Dick R , Sweny P , Moorhead JF. Atherosclerotic renovascular disease causing renal impairment—a case for treatment. Clin Nephrol 1989; 31: 119–22.

Mailloux LU , Napolitano B , Bellud AG , Vernace M , Wilkes BM , Mossey RT. Renal vascular disease causing end-stage renal disease, incidence, clinical correlates and outcomes: a 20-year clinical experience. Am J Kidney Dis 1994; 24: 622–9.

Kalra PS , Mamtora H , Holmes AM , Waldek S. Renovascular disease and renal complications of angiotensin-converting enzyme inhibitor therapy. Quart J Med 1990; 282: 1013–18.

Olin JW , Melia M , Young JR , Graor RA , Risius B. Prevalence of atherosclerotic renal artery stenosis in patients with atherosclerosis elsewhere. Am J Med 1988; (1N): 46N–51N.

Swartbol P , Thorvinger BO , Parsson H , Norgren L. Renal artery stenosis in patients with peripheral vascular disease and its correlation to hypertension. A retrospective study. Int Angiol 1992; 11: 195–9.

von Kemp K , van den Brande P , Peterson T Screening for concomitant diseases in peripheral vascular patients. Results of a systematic approach. Int Angiol 1997; 16: 114–22.

Zierler RE , Bergelin RO , Polissar NL. Carotid and lower extremity arterial disease inpatients with renal artery atherosclerosis. Arch Intern Med 1998; 158: 761–7.

Missouris CG , Papavassiliou MB , Khaw K High prevalence of carotid artery disease in patients with atheromatous renal artery stenosis. Nephrol Dial Transplant 1998; 13: 945–8.

Harding MB , Smith LR , Himmelstein SI Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J Am Soc Nephrol 1992; 2: 1608–16.

Uzu T , Inoue T , Fujii T Prevalence and predictors of renal artery stenosis in patients with myocardial infarction. Am J Kidney Dis 1997; 29: 733–8.

Pickering TG , Herman L , Devereux RB Recurrent pulmonary oedema in hypertension due to bilateral renal artery stenosis: treatment by angioplasty or surgical revascularisation. Lancet 1988; ii: 5512–2.

Missouris CG , Buckenham T , Vallance PJ , MacGregor GA. Renal artery stenosis masquerading as congestive heart failure. Lancet 1993; 341: 1521–2.

Palmar AH , Defeyter IR , Vandenbogaerde JF Renal arterial stenosis as a cause of high output cardiac failure. Int J Cardiol 1989; 22: 404–6.

MacDowall P , Kalra PA , O'Donoghue DJ , Waldeck S , Mamotora H , Brown K. Risk of morbidity from renovascular disease in elderly patients with congestive cardiac failure. Lancet 1998; 352: 13–16.

Navar LG. Integrating multiple paracrine regulators of renal microvascular dynamics. Am J Physiol 1998; 274: F433–F44.

Maher ER , Othman S , Frankel AH , Sweny P , Moorhead JF , Hilson AJ. Captopril-enhanced 99mTc DTPA scintigraphy in the detection of renal-artery stenosis. Nephrol Dial Transplant 1988; 3: 608–11.

Kawamura J , Okada Y , Nishibuchi S , Yoshida O. Transient anuria following administration of angiotensin-I-converting enzyme inhibitor (SQ 14225) in a patient with renal artery stenosis of the solitary kidney successfully treated with renal autotransplantation. J Urol 1982; 127: 111–13.

Konrads A , Meurer KA , Hummerich W Antihypertensive effects of captopril and saralasin in essential and renal hypertension. Am J Cardiol 1982; 49: 1558–60.

Holm EA , Randlov A , Strandgaard S. Brief report: acute renal failure after losartan treatment in a patient with bilateral renal artery stenosis. Blood Press 1996; 5: 360–2.

Ostermann M , Goldsmith DJ , Doyle T , Kingswood JC , Sharpstone P. Reversible acute renal failure induced by losartan in a renal transplant recipient. Postgrad Med J 1997; 73: 105–7.

Missouris CG , Ward DE , Eastwood JB , MacGregor GA. Deterioration in renal function with enalapril but not losartan in a patient with renal artery stenosis in a solitary kidney. Heart 1997; 77: 391–2.

Kothari SS , Sharma S , Sharma M , Saxena A. Enalapril-induced renal artery thrombosis in unilateral renal artery stenosis. Indian Heart J 1997; 49: 192–4.

Scoble JE , Mikhail A , Reidy J , Cook GJR. Individual kidney function in atherosclerotic renal-artery disease. Nephrol Dial Trans 1998; 13: 1048–9.